| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |